首页> 美国卫生研究院文献>Scientific Reports >Synthetic surfactant- and cross-linker-free preparation of highly stable lipid-polymer hybrid nanoparticles as potential oral delivery vehicles
【2h】

Synthetic surfactant- and cross-linker-free preparation of highly stable lipid-polymer hybrid nanoparticles as potential oral delivery vehicles

机译:不含表面活性剂和交联剂的高度稳定的脂质-聚合物杂化纳米颗粒的制备可作为潜在的口服载体

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The toxicity associated with concentrated synthetic surfactants and the poor stability at gastrointestinal condition are two major constraints for practical applications of solid lipid nanoparticles (SLN) as oral delivery vehicles. In this study, a synthetic surfactant-free and cross-linker-free method was developed to fabricate effective, safe, and ultra-stable lipid-polymer hybrid nanoparticles (LPN). Bovine serum albumin (BSA) and dextran varying in molecular weights were first conjugated through Maillard reaction and the conjugates were exploited to emulsify solid lipid by a solvent diffusion and sonication method. The multilayer structure was formed by self-assembly of BSA-dextran micelles to envelope solid lipid via a pH- and heating-induced facile process with simultaneous surface deposition of pectin. The efficiency of different BSA-dextran conjugates was systematically studied to prepare LPN with the smallest size, the most homogeneous distribution and the greatest stability. The molecular interactions were characterized by Fourier transform infrared and fluorescence spectroscopies. Both nano spray drying and freeze-drying methods were tested to produce spherical and uniform pectin-coated LPN powders that were able to re-assemble nanoscale structure when redispersed in water. The results demonstrated the promise of a synthetic surfactant- and cross-linker-free technique to prepare highly stable pectin-coated LPN from all natural biomaterials as potential oral delivery vehicles.
机译:与浓缩的合成表面活性剂有关的毒性以及在胃肠道条件下的不良稳定性是将固体脂质纳米颗粒(SLN)用作口服给药载体的两个主要限制因素。在这项研究中,开发了一种无表面活性剂和无交联剂的合成方法,以制造有效,安全和超稳定的脂质-聚合物杂化纳米颗粒(LPN)。首先通过美拉德反应将分子量不同的牛血清白蛋白(BSA)和右旋糖酐偶联,然后通过溶剂扩散和超声处理方法利用偶联物乳化固体脂质。多层结构是通过BSA-葡聚糖胶束的自组装形成的,通过pH和加热诱导的简便过程,同时将果胶表面沉积,从而包封固体脂质。系统地研究了不同BSA-右旋糖酐共轭物的效率,以制备具有最小尺寸,最均匀分布和最大稳定性的LPN。通过傅立叶变换红外和荧光光谱表征分子相互作用。测试了纳米喷雾干燥和冷冻干燥方法,以生产球形和均匀的果胶涂层LPN粉末,当重新分散在水中时,它们可以重新组装纳米级结构。结果表明,无表面活性剂和无交联剂的合成技术有望从所有天然生物材料中制备高度稳定的果胶涂层LPN,作为潜在的口服给药载体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号